# Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage

> **NCT06322953** · PHASE3 · RECRUITING · sponsor: **Walton Centre NHS Foundation Trust** · enrollment: 1084 (estimated)

## Conditions studied

- Traumatic Intracranial Haemorrhage

## Interventions

- **DRUG:** Direct-Acting Oral Anticoagulants (used as per local standard practice)

## Key facts

- **NCT ID:** NCT06322953
- **Lead sponsor:** Walton Centre NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 1084 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06322953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06322953, "Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06322953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*